Scientists at Oxford University are developing a new Ebola vaccine that could enter clinical trials within two to three months, as global health authorities race to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo linked to the Bundibugyo strain of the virus.
Professor Teresa Lambe of the Oxford Vaccine Group said the vaccine uses the same technology developed by UK scientists during the Covid-19 pandemic. https://reut.rs/4dFWu8Q
#ebola #vaccine #oxford #DRC #DemocraticRepublicofCongo